Open Trials

AMR locations nationwide are conducting research studies and/or trials.
Please scroll down to see our current opportunities.

COVID-19 Clinical Research Studies

AMR locations nationwide are currently conducting or will soon be conducting several COVID-19 investigational clinical research studies.  As with all studies, some exclusions will apply.  However, we will have multiple studies needing participants from all walks of life.  Compensation will be available for time and travel.

At this time, there is no proven prevention vaccine so this would offer potential coverage and an opportunity to help advance science in developing a proven vaccine.

COVID-19 Investigational Vaccine (ages 16+) (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase I)
COVID-19 Investigational Vaccine Clinical Research Study (Phase II)
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase I)
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase I)
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
COVID-19 Investigational Treatment Clinical Research Study (Phase II)
COVID-19 Investigational Vaccine (ages 18+ and 5-17) (Phase III)
COVID-19 Investigational Vaccine (ages 16+) (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
COVID-19 Investigational Vaccine (ages 16+) (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase II)
COVID-19 Investigational Vaccine Clinical Research Study (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase III)
COVID-19 Investigational Vaccine (ages 16+) (Phase III)

COVID-19 Investigational Vaccine Clinical Research Study (Phase III)

Smoking Cessation Clinical Research Study (daily smokers 18+)

AMR locations nationwide are participating in ORCA-2, a multicenter, double-blinded, randomized, placebo-controlled phase III trial evaluating the efficacy and safety of cytisinicline in adult smokers.  In this study, the sponsor, Achieve Life Sciences, wants to find out if utilizing cytisinicline can increase cigarette smoking abstinence.  To qualify, participants must be male or female, ages 18+ who are currently daily smokers (averaging at least 10 cigarettes per day upon completing a 7-day screening smoking diary) and who intend to quit smoking.  Other study requirements apply.

Healthy Volunteer Clinical Research Studies

AMR has multiple Healthy Volunteer Clinical Research Studies enrolling throughout the continental United States.  A “healthy volunteer” is someone with no known significant health problems who participates in a clinical research study to test a new drug, an investigational vaccination, a medical device or a medical intervention.    No insurance is required and qualified volunteers may receive compensation for their time and travel.  Listed below are our current and upcoming Healthy Volunteer clinical research studies listed by indication.

RSV Vaccine Clinical Research Study (healthy volunteers ages 60+)

This is an Investigational RSV Vaccine Clinical Research Study for healthy volunteers 60+ years of age.  Respiratory syncytial virus (RSV) causes infections of the lungs and respiratory tract.  In adults and older, healthy children, RSV symptoms are mild and typically mimic the common cold.

El Dorado:  316-600-5127
[email protected]
Kansas City:  816-943-0770
[email protected]
Miami:  305-445-5637
[email protected]
Chikungunya Vaccine Clinical Research Study (healthy volunteers ages 18+)

Chikungunya virus (CHIKV) is spread by the bite of an infected mosquito. Outbreaks have occurred in Africa, Asia, Europe and the Indian and Pacific Oceans. This Investigational Chikungunya Vaccine Clinical Research Study is an important part of preventing future global pandemics.

El Dorado: 316-600-5127
[email protected]
Kansas City: 816-943-0770
[email protected]
Knoxville: 865-305-3784
[email protected]
Las Vegas: 702-545-6840
[email protected]
Lexington: 859-264-8999
[email protected]
Mobile: 251-414-1984
[email protected]
New Orleans: 504-821-2273
[email protected]
Newton: 316-283-0828
[email protected]
Norfolk: 757-627-7446
[email protected]
Tempe: 602-759-7559
[email protected]
Wichita-East: 316-689-6652
[email protected]
Flu Vaccine Clinical Research Study (healthy volunteers 50+)

This Investigational Flu Vaccine Clinical Research Study is for healthy volunteers 50 years of age and older.

Kansas City: 816-943-0770
[email protected]
Lexington: 859-264-8999
[email protected]
Mobile: 251-414-1984
[email protected]
Newton: 316-283-0828
[email protected]
Tempe: 602-759-7559
[email protected]
Wichita-East: 316-689-6652
[email protected]

Current Trials By Location

Fort Myers
Congenital Adrenal Hyperplasia
Kansas City
Acid Reflux
Lexington
Dietary Supplement for Skin Infections
Mobile
Ebola Vaccine
Norfolk
Rosacea
Knoxville
Ebola Vaccine
New Orleans
High Blood Pressure
Newton
Pediatric Constipation
Wichita – East
GERD
Wichita – West
Endometriosis
El Dorado
Low Testosterone

Refer-A-Friend Program

Earn extra cash.*
“Refer-A-Friend” at many of our locations to earn extra cash. If a friend or family member is deemed eligible to participate in one of our clinical research studies, you will receive $50.00!* There is no limit on the number of referrals you can provide. This is intended for your family and friends and you may not advertise or make any general solicitations for individuals to participate in a study. Compensation is mailed out after your referral has qualified for (randomized into) the study. For questions about the Refer-A-Friend program, contact the AMR location nearest you.
*Some restrictions apply. Not all studies are eligible for the Refer-A-Friend program. Ask an AMR representative for details.
Refer-A-Friend